Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NYXH
NYXH logo

NYXH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nyxoah SA (NYXH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.230
1 Day change
-0.92%
52 Week Range
8.640
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Nyxoah SA (NYXH) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown significant revenue growth in its latest quarter, its financials still reflect substantial losses, and there are no strong positive catalysts or proprietary trading signals to suggest immediate upside potential. The stock's technical indicators are neutral, and analysts have recently lowered their price targets, reflecting cautious sentiment. Given the lack of recent news, options data, or significant trading trends, it is advisable to hold off on buying this stock for now.

Technical Analysis

The MACD is positive and expanding, indicating a mild bullish momentum. RSI is neutral at 57.257, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong directional trend. Key support is at 2.885, and resistance is at 3.535. Overall, the technical indicators are neutral.

Positive Catalysts

  • Revenue increased by 346.87% YoY in Q4 2025, indicating strong top-line growth. The stock has a 16.01% chance of gaining in the next month based on historical candlestick patterns.

Neutral/Negative Catalysts

  • Net income remains negative at -$23.51M, though it has improved YoY. Gross margin dropped by 12.59% YoY. Analysts have recently lowered price targets, reflecting cautious sentiment. No recent news or significant trading trends from hedge funds or insiders.

Financial Performance

In Q4 2025, revenue increased significantly by 346.87% YoY to $5.64M. However, net income remains negative at -$23.51M, though it improved by 37.11% YoY. EPS also improved to -0.59, up 28.26% YoY. Gross margin dropped to 64.23%, down 12.59% YoY, indicating some pressure on profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered their price targets recently. Stifel reduced the target to $8 from $10 while maintaining a Buy rating, citing reimbursement challenges. Baird lowered the target to $4.62 from $5.87 with a Neutral rating, reflecting cautious optimism as the U.S. rollout progresses. Overall, sentiment is mixed to cautious.

Wall Street analysts forecast NYXH stock price to rise
5 Analyst Rating
Wall Street analysts forecast NYXH stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 3.260
sliders
Low
5.82
Averages
10.41
High
13
Current: 3.260
sliders
Low
5.82
Averages
10.41
High
13
Stifel
Jonathan Block
Buy
downgrade
$10 -> $8
AI Analysis
2026-04-10
Reason
Stifel
Jonathan Block
Price Target
$10 -> $8
AI Analysis
2026-04-10
downgrade
Buy
Reason
Stifel analyst Jonathan Block lowered the firm's price target on Nyxoah to $8 from $10 and keeps a Buy rating on the shares. The firm's checks suggest the Q1 reimbursement environment weighed on HGNS volumes, says the analyst, who expects these issues to impact Q1 results and takes a more conservative 2026 view.
Baird
David Rescott
Neutral
downgrade
2026-03-23
Reason
Baird
David Rescott
Price Target
2026-03-23
downgrade
Neutral
Reason
Baird analyst David Rescott lowered the firm's price target on Nyxoah to $4.62 from $5.87 and keeps a Neutral rating on the shares. The firm updatedits mdel as its U.S. rollout gains traction but still in its early days.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NYXH
Unlock Now

People Also Watch